comparemela.com

Page 19 - Ajay Kirtane News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Revascularization s Benefits in HFrEF Linked to Gains in LV Function

In a surprise, PCI seemed to have an edge over CABG. Data from the ongoing REVIVED-BCIS2 trial may provide clarity.

United statesAjay kirtaneDavid tehraniArnoldh setoLos angelesRaghavas velagaletiMd long beach va medical centerVeterans affairsPresbyterian columbia university irving medical centerHealthcare systemColumbia university irving medical centerRonald reaganLong beach

FFR Not Better, Just Different From IVUS for PCI

In a head-to-head comparison in the FLAVOUR trial, IVUS- and FFR-guided PCI produced similar outcomes but had differing strengths.

New yorkUnited statesSoult ukpyolsiSouth koreaSalt lake cityUniversity of utahAjay kirtaneBon kwon kooPhilips spectraneticsAmerican college of cardiologyBoston scientificPresbyterian columbia university irving medical centerSeoul south korea national university hospitalAmerican collegeFractional flow reserve andClinical outcomes

FLAVOUR: FFR as Good as IVUS for Intermediate Coronary Stenoses

At 2 years, there was no difference in the primary outcome, but the FFR-guided strategy led to fewer stents being implanted.

New yorkUnited statesSoult ukpyolsiSouth koreaSalt lake cityUniversity of utahAjay kirtaneBon kwon kooRoxana mehranPhd seoul national university hospitalMd university of utah school medicineAmerican college of cardiologyPresbyterian columbia university irving medical centerAmerican collegeSeoul national university hospitalColumbia university irving medical center

ReCor Medical s RADIANCE-II Pivotal Trial of Paradise uRDN System Completes Enrollment

March 29, 2022—ReCor Medical, Inc., a fully owned subsidiary of Otsuka Medical Devices Co., Ltd., announced completion of enrollment in the RADI

New yorkUnited statesFrance generalAjay kirtaneMichel aziziGeorges pompidouVagelos college of physiciansHypertension excellence centerOtsuka medical devices co ltdRecor medical incRecor medicalCoprincipal investigatorsParis citExcellence centerColumbia universityVagelos college

ReCor Medical completes enrollment in renal denervation trial for treating hypertension

ReCor Medical announced that it completed enrollment in its Radiance-II pivotal trial of the Paradise ultrasound renal denervation system.

New yorkUnited statesColumbia universityFrance generalAjay kirtaneMichel aziziGeorges pompidouVagelos college of physiciansHypertension excellence centerRecor medicalCor medicalCalifornia based recor medicalParis citExcellence centerVagelos collegeNew york presbyterian hospital

vimarsana © 2020. All Rights Reserved.